Immunomedics, Inc. (IMMU) Reports In-Line Q2 Loss of 10c/Share

February 10, 2014 4:29 PM EST Send to a Friend

Immunomedics, Inc. (NASDAQ: IMMU) reported Q2 EPS of ($0.10) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Immunomedics, Inc. (IMMU) Reports In-Line Q2 Loss of 10c/Share

Member Login

Free News Feed